Patent · US Expired

Anticancer peptide compositions

US7326679B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 29, 2004
Grant dateFeb 5, 2008
Priority date
Expiry dateOct 29, 2024

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/1709
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for inhibiting angiogenesis associated with tumors and reducing tumor growth.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.